Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gangliosides block antigen presentation by human monocytes

A Heitger1, S Ladisch

  • 1Glycobiology Program, Center for Cancer and Transplantation Biology, Children's Research Institute, Washington, DC 20010, USA.

Biochimica Et Biophysica Acta
|September 27, 1996
PubMed
Summary

Tumor gangliosides inhibit T-cell proliferation by impairing antigen presentation in monocytes. This disruption prevents effective immune responses against tumors by blocking T-lymphocyte interactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mannan-binding lectin deficiency attenuates acute GvHD in pediatric hematopoietic stem cell transplantation.

Bone marrow transplantation·2015
Same author

Concurrent FOXP3- and CTLA4-associated genetic predisposition and skewed X chromosome inactivation in an autoimmune disease-prone family.

European journal of endocrinology·2012
Same author

Regulation of expression and function of IDO in human dendritic cells.

Current medicinal chemistry·2011
Same author

Long-term remission in pediatric Wegener granulomatosis following allo-SCT after reduced-intensity conditioning.

Bone marrow transplantation·2010
Same author

Ganglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth.

Oncogene·2010
Same author

[Stable transfection of DAOY cells with a GM3 synthase antisense construct and transient reduction in ganglioside content].

Biomeditsinskaia khimiia·2006

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Immunology

Background:

  • Gangliosides are immunosuppressive molecules released by tumor cells.
  • These molecules inhibit monocyte accessory cell function, but the precise defect is unclear.
  • Understanding this defect is crucial for developing anti-tumor immunotherapies.

Purpose of the Study:

  • To determine the specific cellular defect in monocytes caused by gangliosides.
  • To investigate if gangliosides affect suppressor cell induction, intracellular antigen processing, or intercellular antigen presentation.
  • To elucidate the mechanism by which gangliosides impair monocyte accessory function.

Main Methods:

  • Utilized tetanus toxoid (TT)-induced lymphoproliferative response assays.
  • Incubated human monocytes with gangliosides and assessed T-cell proliferation.

Related Experiment Videos

  • Evaluated T-cell responses to anti-CD3 and control monocytes in the presence of ganglioside-exposed monocytes.
  • Tested responses to a TT peptide fragment that does not require processing.

    • Main Results:

    • Gangliosides inhibited T-cell proliferation after antigen processing was complete.
    • Ganglioside-exposed monocytes did not induce suppressor cell activity.
    • Monocyte exposure to gangliosides completely inhibited responses to a processed-independent TT peptide fragment.
    • Gangliosides interfere with antigen presentation by monocytes.

    Conclusions:

    • Tumor-derived gangliosides impair monocyte accessory cell function at the antigen presentation stage.
    • This interference prevents effective anti-tumor cellular immune responses by disrupting T-lymphocyte interactions.
    • Targeting ganglioside-mediated immunosuppression could enhance host anti-tumor immunity.